| Code | CSB-RA980158MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to reference antibody TK-001, targeting vascular endothelial growth factor (VEGF). VEGF is a critical signaling protein that regulates angiogenesis and vascular permeability by binding to VEGF receptors on endothelial cells. This growth factor plays essential roles in physiological processes including wound healing and embryonic development, but also contributes to pathological conditions when dysregulated. Elevated VEGF expression is associated with tumor angiogenesis in various cancers, diabetic retinopathy, age-related macular degeneration, and other diseases characterized by abnormal blood vessel formation.
As a biosimilar to TK-001, this antibody provides researchers with a cost-effective alternative for investigating VEGF-mediated pathways and mechanisms. It serves as a valuable tool for studying angiogenesis, tumor biology, vascular biology, and VEGF signaling cascades in various experimental models. This product enables scientists to explore the role of VEGF in disease pathogenesis and evaluate potential therapeutic interventions targeting angiogenic processes across multiple research disciplines.
There are currently no reviews for this product.